Paramount Bed Holdings Co., Ltd. (TYO:7817)
Japan
· Delayed Price · Currency is JPY 2,587.00
-1.00 (-0.04%)
Jun 6, 2025, 3:30 PM JST
Paramount Bed Holdings Revenue
In the fiscal year ending March 31, 2025, Paramount Bed Holdings had annual revenue of 108.58B JPY with 2.42% growth. Paramount Bed Holdings had revenue of 33.51B in the quarter ending March 31, 2025, with 1.67% growth.
Revenue
108.58B
Revenue Growth
+2.42%
P/S Ratio
1.34
Revenue / Employee
26.32M
Employees
4,126
Market Cap
145.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 108.58B | 2.57B | 2.42% |
| Mar 31, 2024 | 106.02B | 7.01B | 7.08% |
| Mar 31, 2023 | 99.01B | 8.66B | 9.58% |
| Mar 31, 2022 | 90.35B | 3.18B | 3.65% |
| Mar 31, 2021 | 87.17B | 4.79B | 5.82% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |